Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
UPAMOSTAT
ID: ALA4206119
Max Phase: Phase
Molecular Formula: C32H47N5O6S
Molecular Weight: 629.82
Molecule Type: Small molecule
Associated Items:
ID: ALA4206119
Max Phase: Phase
Molecular Formula: C32H47N5O6S
Molecular Weight: 629.82
Molecule Type: Small molecule
Associated Items:
Synonyms (4): Mesupron | Upamostat | Wx-671 | WX-671
Synonyms from Alternative Forms(4):
Canonical SMILES: CCOC(=O)N1CCN(C(=O)[C@H](Cc2cccc(/C(N)=N\O)c2)NS(=O)(=O)c2c(C(C)C)cc(C(C)C)cc2C(C)C)CC1
Standard InChI: InChI=1S/C32H47N5O6S/c1-8-43-32(39)37-14-12-36(13-15-37)31(38)28(17-23-10-9-11-24(16-23)30(33)34-40)35-44(41,42)29-26(21(4)5)18-25(20(2)3)19-27(29)22(6)7/h9-11,16,18-22,28,35,40H,8,12-15,17H2,1-7H3,(H2,33,34)/t28-/m0/s1
Standard InChI Key: HUASEDVYRABWCV-NDEPHWFRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: Yes | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 629.82 | Molecular Weight (Monoisotopic): 629.3247 | AlogP: 4.34 | #Rotatable Bonds: 11 |
Polar Surface Area: 154.63 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.24 | CX Basic pKa: 4.96 | CX LogP: 4.85 | CX LogD: 4.78 |
Aromatic Rings: 2 | Heavy Atoms: 44 | QED Weighted: 0.14 | Np Likeness Score: -0.89 |
1. Buckley BJ, Aboelela A, Minaei E, Jiang LX, Xu Z, Ali U, Fildes K, Cheung CY, Cook SM, Johnson DC, Bachovchin DA, Cook GM, Apte M, Huang M, Ranson M, Kelso MJ.. (2018) 6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer., 61 (18): [PMID:30130401] [10.1021/acs.jmedchem.8b00838] |
2. Unpublished dataset, |
3. Indorf P, Kubitza C, Scheidig AJ, Kunze T, Clement B.. (2020) Drug Metabolism by the Mitochondrial Amidoxime Reducing Component (mARC): Rapid Assay and Identification of New Substrates., 63 (12): [PMID:31790578] [10.1021/acs.jmedchem.9b01483] |
Source(2):